Zevra Therapeutics, Inc. (ZVRA)

Zevra Therapeutics Revenue

Zevra Therapeutics had revenue of $3.70M in the quarter ending September 30, 2024, with 27.63% growth. This brings the company's revenue in the last twelve months to $24.49M, up 47.85% year-over-year. In the year 2023, Zevra Therapeutics had annual revenue of $27.46M with 170.26% growth.

• Revenue (ttm): $24.49M
• Revenue Growth: +47.85%
• P/S Ratio: 13.99
• Revenue / Employee: $354,913
• Employees: 69
• Market Cap: 435.01M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	27.46M	17.30M	170.26%
Dec 31, 2022	10.16M	-18.49M	-64.53%
Dec 31, 2021	28.65M	15.36M	115.61%
Dec 31, 2020	13.29M	449.00K	3.50%
Dec 31, 2019	12.84M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.